COLL Operating Income Growth
Collegium Pharmaceutical Inc · Operating Income Growth
COLL Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported22.17%period ending
COLL TTM Operating Income YoY % (-52.32% → 22.17%)
Year-over-year change
High-resolution chart · PNG
COLL operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 22.1709% | |
| 33.6406% | |
| 5.7335% | |
| -18.0641% | |
| -36.2904% | |
| -25.9113% | |
| 1.7573% | |
| 65.3183% | |
| 120.1959% | |
| 182.2325% | |
| 401.0985% | |
| 1,031.7675% | |
| 589.9036% | |
| 600.486% | |
| 89.0118% | |
| -118.8176% | |
| -126.1385% | |
| -118.7651% | |
| -68.6513% | |
| 71.7469% | |
| 461.5223% | |
| 932.2369% | |
| 336.7863% | |
| 474.6192% | |
| 184.702% | |
| 50.229% | |
| -14.8078% | |
| 78.9442% | |
| 70.522% | |
| 73.3193% | |
| 72.5834% | |
| 42.337% | |
| 47.6786% | |
| 35.5982% | |
| 19.8072% | |
| -12.5153% | |
| -67.5488% | |
| -161.6139% | |
| -249.6692% | |
| -265.144% | |
| -225.7859% | |
| -121.4416% | |
| -52.3211% |